Provided By PR Newswire
Last update: Jul 31, 2024
-- Conference Call Scheduled for Tuesday, August 6, 2024, at 8:00 a.m. ET --
NEWTON, Mass., July 31, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2024 financial results on Tuesday, August 6, 2024. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Tuesday, August 6, 2024, to discuss the financial results and other company updates.
Read more at prnewswire.com